University launches hub for pregnant women with pre-existing medical conditions
Norfolk and Norwich University Hospitals Foundation Trust opens centre to increase survival rate among pregnant women managing other conditions
Read More
Tag: survival
Imfinzi, tremelimumab combo boosts survival in lung cancer
The POSEIDON trial is the first Phase III study to demonstrate an overall survival benefit with tremelimumab
Read More
Kisqali success continues with positive late-stage trial results
The success marks the second Phase III clinical trial in which Kisqali met overall survival.
Read More
UK behind Europe in cancer diagnosis, treatment, survival
The UK is lagging behind Europe in the diagnosis and treatment of cancer, finds a new report compiled by Swedish Institute for Health Economics for the Association of the British Pharmaceutical Industry.
Read More
BMS’ Opdivo shown to improve five-year lung cancer survival
Bristol-Myers Squibb has unveiled “unprecedented” long-term survival data for its cancer immunotherapy Opdivo, showing that nearly one in six patients with previously-treated, advanced non-small cell lung cancer (NSCLC) were still alive at five years.
Read More
Study links cancer symptom awareness with survival
Low awareness of the potential symptoms of cancer is linked to a lower chance of survival, suggests new research published in the British Journal of Cancer.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
